HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
This Quarter Return
-0.7%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$64.8M
AUM Growth
+$64.8M
(+3.4%)
Cap. Flow
+$4.5M
Cap. Flow
% of AUM
6.94%
Top 10 Holdings %
Top 10 Hldgs %
84.95%
Holding
40
New
5
Increased
9
Reduced
4
Closed
7
Top Buys
| 1 |
AstraZeneca
AZN
|
$3.18M |
| 2 |
ANI Pharmaceuticals
ANIP
|
$2.25M |
| 3 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$1.5M |
| 4 |
Pfizer
PFE
|
$1.48M |
| 5 |
ProShares UltraShort NASDAQ Biotechnology
BIS
|
$1.07M |
Top Sells
| 1 |
QLTI
QLT Inc
QLTI
|
$3.48M |
| 2 |
HNT
HEALTH NET INC
HNT
|
$3.4M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$954K |
| 4 |
Baxter International
BAX
|
$736K |
| 5 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$682K |
Sector Composition
| 1 | Healthcare | 79.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRI
1
DELISTED
Albany Molecular Research Inc
AMRI
| $10M | 8.41% | 498,200 +50,000 | +11% | +$1.01M |
|
|
2
AstraZeneca
AZN
$248B
| $7.43M | 6.23% | 100,000 +42,761 | +75% | +$3.18M |
|
|
3
ANI Pharmaceuticals
ANIP
$2.03B
| $6.85M | 5.75% | 199,000 +65,442 | +49% | +$2.25M |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $6.82M | 5.72% | 130,000 | – | – |
|
|
AUXL
5
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $4.6M | 3.86% | 229,481 +50,000 | +28% | +$1M |
|
6
Quest Diagnostics
DGX
$20.3B
| $4.53M | 3.8% | 77,208 | – | – |
|
7
Merck
MRK
$210B
| $4.45M | 3.74% | 77,000 | – | – |
|
|
8
Pfizer
PFE
$141B
| $4.45M | 3.73% | 150,000 +50,000 | +50% | +$1.48M |
|
9
Sanofi
SNY
$121B
| $3.07M | 2.57% | 57,735 | – | – |
|
|
10
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
| $2.85M | 2.39% | 200,000 +75,000 | +60% | +$1.07M |
|
|
IPXL
11
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.5M | 1.26% | +50,000 | New | +$1.5M |
|
|
SRNE
12
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.38M | 1.16% | 204,968 +104,968 | +105% | +$709K |
|
13
ProShares UltraShort Russell2000
TWM
$34.5M
| $1.08M | 0.9% | 25,000 | – | – |
|
|
KIN
14
DELISTED
Kindred Biosciences, Inc.
KIN
| $932K | 0.78% | +50,000 | New | +$932K |
|
|
SCMP
15
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $667K | 0.56% | +96,630 | New | +$667K |
|
|
FCSC
16
DELISTED
Fibrocell Science Inc.
FCSC
| $629K | 0.53% | 157,769 +50,000 | +46% | +$199K |
|
|
CEMP
17
DELISTED
Cempra, Inc.
CEMP
| $537K | 0.45% | +50,000 | New | +$537K |
|
|
ZGNX
18
DELISTED
Zogenix, Inc.
ZGNX
| $503K | 0.42% | 250,000 +150,000 | +150% | +$302K |
|
19
Galmed Pharmaceuticals
GLMD
$6.96M
| $487K | 0.41% | 50,000 | – | – |
|
|
ARIA
20
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $478K | 0.4% | +75,000 | New | +$478K |
|
|
VXRT
21
DELISTED
Vaxart
VXRT
| $415K | 0.35% | 145,507 -100,000 | -41% | -$285K |
|
22
Rigel Pharmaceuticals
RIGL
$697M
| $363K | 0.3% | 100,000 -50,000 | -33% | -$182K |
|
23
Imunon
IMNN
$15M
| $347K | 0.29% | 100,000 -50,000 | -33% | -$174K |
|
|
STML
24
DELISTED
Stemline Therapeutics, Inc.
STML
| $242K | 0.2% | 16,464 | – | – |
|
25
Cytokinetics
CYTK
$4.23B
| $199K | 0.17% | 41,666 -15,000 | -26% | -$71.6K |
|